-
581por Maqsood, Shoaib, Zhou, Yan, Lin, Xintong, Huang, Shuai, Jamil, Ihsan, Shahzad, Khurram“…Hypotheses H9a, H9b, H9f, and H9g were validated and support the use of CIT to boost enterprise production and consumption. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
582por Liu, Xiaojuan, Gong, Qin, Zhao, Chenning, Wang, Dengliang, Ye, Xianming, Zheng, Guixia, Wang, Yue, Cao, Jinping, Sun, Chongde“…CitF3′H catalyzed numerous flavonoids and favored naringenin in yeast assays. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
583por Grambow-Velilla, Julia, Seban, Romain-David, Chouahnia, Kader, Assié, Jean-Baptiste, Champion, Laurence, Girard, Nicolas, Bonardel, Gerald, Matton, Lise, Soussan, Michael, Chouaïd, Christos, Duchemann, Boris“…Conclusion: Baseline 18F-FDG PET/CT using TMTV could help to predict worse outcomes for ES-SCLC patients undergoing first-line CIT. This suggests that baseline TMTV may be used to identify patients that are unlikely to benefit from CIT.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
584por James, Eddie A., Holers, V. Michael, Iyer, Radhika, Prideaux, E. Barton, Rao, Navin L., Rims, Cliff, Muir, Virginia S., Posso, Sylvia E., Bloom, Michelle S., Zia, Amin, Elliott, Serra E., Adamska, Julia Z., Ai, Rizi, Brewer, R. Camille, Seifert, Jennifer A., Moss, LauraKay, Barzideh, Saman, Demoruelle, M. Kristen, Striebich, Christopher C., Okamoto, Yuko, Sainbayar, Enkhtsogt, Crook, Alexandra A., Peterson, Ryan A., Vanderlinden, Lauren A., Wang, Wei, Boyle, David L., Robinson, William H., Buckner, Jane H., Firestein, Gary S., Deane, Kevin D.“…Antibody-antigen array analyses show that antibodies targeting cit-clusterin, cit-fibrinogen and cit-histone H4 are elevated in At-Risk and Early RA participants, with the highest levels of antibodies detected in those with Early RA. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
585por Ding, Xiao, Cao, He, Chen, Xiao, Jin, Haofan, Liu, Ziling, Wang, Guanjun, Cai, Lu, Li, Dan, Niu, Chao, Tian, Huimin, Yang, Lei, Zhao, Yuguang, Li, Wei, Cui, Jiuwei“…No significant adverse reactions occurred in patients undergoing CIT. CONCLUSIONS: CIT maintenance therapy in SCLC prolonged survival with only minimal side effects. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
586por Yan, Liping, Hu, Jianhua, Lei, Jing, Shi, Zhiyu, Xiao, Qian, Bi, Zhenwei, Yao, Lu, Li, Yuan, Chen, Yuqing, Fang, An, Li, Hui, Song, Suquan, Liao, Min, Zhou, Jiyong“…Compared with the IDEXX IBV Ab Test kit, CIT and RDT have a sensitivity and specificity of at least 98.88% and 91.67%, respectively. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
587Publicado 2019“…OBJECTIVE: To analyze the survival and first-line immune-chemotherapy (CIT) of chronic lymphocytic leukemia (CLL) with abnormal TP53 gene in the era of traditional CIT. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
588por Al-Samkari, Hanny, Parnes, Aric D., Goodarzi, Katayoon, Weitzman, James I., Connors, Jean M., Kuter, David J.“…Chemotherapy-induced thrombocytopenia (CIT) frequently complicates cancer treatment causing chemotherapy treatment delays, dose reductions, and discontinuation. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
589“…METHODS: Male Sprague-Dawley rats were divided into four groups: Control-Sedentary, CIT- and IIT-treated diabetic sedentary, and CIT-exercised trained (aerobic/resistance; DARE). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
590por Okamoto, Yuko, Devoe, Stephanie, Seto, Nickie, Minarchick, Valerie, Wilson, Timothy, Rothfuss, Heather M., Mohning, Michael P., Arbet, Jaron, Kroehl, Miranda, Visser, Ashley, August, Justin, Thomas, Stacey M., Charry, Laura Lenis, Fleischer, Chelsie, Feser, Marie L., Frazer‐Abel, Ashley A., Norris, Jill M., Cherrington, Brian D., Janssen, William J., Kaplan, Mariana J., Deane, Kevin D., Holers, V. Michael, Demoruelle, M. Kristen“…In at‐risk subjects, sputum IgA ACPA correlated with the percentage of neutrophils that underwent Cit‐H3+ NET formation (r = 0.49, P = 0.002) and levels of Cit‐H3+ NET remnants (r = 0.70, P < 0.001). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
591por Jaus, Alexandra, Rhyn, Peter, Haldimann, Max, Brüschweiler, Beat J., Fragnière Rime, Céline, Jenny-Burri, Judith, Zoller, Otmar“…OTA, 2′R-ochratoxin A (2′R-OTA), ochratoxin alpha (OTα), CIT and dihydrocitrinone (DH-CIT) were analysed using validated targeted methods including precipitation and online SPE clean-up. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
592por Hashimoto, Takayuki, Demizu, Yusuke, Numajiri, Haruko, Isobe, Tomonori, Fukuda, Shigekazu, Wakatsuki, Masaru, Yamashita, Haruo, Murayama, Shigeyuki, Takamatsu, Shigeyuki, Katoh, Hiroyuki, Murata, Kazutoshi, Kohno, Ryosuke, Arimura, Takeshi, Matsuura, Taeko, Ito, Yoichi M.“…MATERIALS AND METHODS: From April 2001 to March 2013, 19,585 patients were treated with proton beam therapy (PBT) or carbon ion therapy (CIT) at 8 institutions. Of these, 69 patients (0.4%, PBT 46, CIT 22, and PBT + CIT 1) with CIEDs (64 pacemakers, 4 implantable cardioverter defibrillators, and 1 with a cardiac resynchronization therapy defibrillator) were retrospectively reviewed. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
593por Kyei, Nicholas N. A., Cramer, Benedikt, Humpf, Hans-Ulrich, Degen, Gisela H., Ali, Nurshad, Gabrysch, Sabine“…Aflatoxins (AFs), ochratoxin A (OTA), citrinin (CIT), fumonisin B(1) (FB(1)), zearalenone (ZEN), and deoxynivalenol (DON) are mycotoxins that may contaminate diets, especially in low-income settings, with potentially severe health consequences. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
594por Soff, Gerald A., Ray-Coquard, Isabelle, Rivera, Luis J. Marfil, Fryzek, Jon, Mullins, Megan, Bylsma, Lauren C., Park, Joseph K.“…BACKGROUND: Currently, there are no approved options to prevent or treat chemotherapy-induced thrombocytopenia (CIT). We performed a systematic literature review and meta-analysis on use of thrombopoietic agents for CIT. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
595por Seith, Ferdinand, Forschner, Andrea, Weide, Benjamin, Gückel, Brigitte, Schwartz, Martin, Schwenck, Johannes, Othman, Ahmed E, Fenchel, Matthias, Garbe, Claus, Nikolaou, Konstantin, Schwenzer, Nina, la Fougère, Christian, Pfannenberg, Christina“…Response assessment or prediction to checkpoint inhibitor therapy (CIT) is an unsolved problem in current routine diagnostics of patients with melanoma. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
596por Shibata, Masa‐Aki, Fukushima, Shoji, Asakawa, Emiko, Hirose, Masao, Ito, Nobuyuki“…In contrast, simultaneous treatment with Na‐Cit and AsA caused an increase of the hyperplasia development. …”
Publicado 1992
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
597“…A fluorescent immunochromatographic test strip (FICTS) based on the use of europium nanoparticles (EuNPs) was developed and applied to detect citrinin (CIT) in Monascus fermented food. The sensitivity of the immunoassay to detect CIT was greatly improved by the use of a specific monoclonal antibody to attach EuNPs to form a probe. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
598por Flores-Ramírez, Anaisa Genoveva, Tovar-Villegas, Verónica Ivette, Maharaj, Arun, Garay-Sevilla, Ma Eugenia, Figueroa, Arturo“…Therefore, this review examined the efficacy of L-Cit supplementation and aerobic training interventions on vascular and metabolic parameters in obese individuals.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
599por Egli, Jerome, Heiler, Stefan, Weber, Felix, Steiner, Guido, Schwandt, Timo, Bray-French, Katharine, Klein, Christian, Fenn, Sebastian, Lotz, Gregor P., Opolka-Hoffmann, Eugenia, Kraft, Thomas E., Petersen, Laetitia, Moser, Rebecca, DeGeer, Jonathan, Siegel, Michel, Finke, Daniela, Bessa, Juliana, Iglesias, Antonio“…Reversal of this unresponsiveness by the action of CitAbs on T cells may be the cause of undesired ADA responses. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
600por Boccalini, Cecilia, Nicastro, Nicolas, Peretti, Debora Elisa, Caminiti, Silvia Paola, Perani, Daniela, Garibotto, Valentina“…METHODS: We included 123 pDLB patients (male/female: 77/46) and 78 control subjects (male/female: 34/44) for comparison, who underwent (123)I-FP-CIT SPECT imaging. We assessed sex differences in the dopaminergic activity of the nigrostriatal and mesolimbic systems using regional-based and voxel-wise analyses of (123)I-FP-CIT binding. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto